Kidney Injury Biomarkers in Hypertensive, Diabetic, and Nephropathy Rat Models Treated with Contrast Media

Toxicologic Pathology

Volumn 41, Issue 4, 2013, Pages 662-680

  Rouse, Rodney L ^a   Stewart, Sharron R ^a   Thompson, Karol L ^a   Zhang, Jun ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

acute kidney injury; contrast media; contrast nephropathy; kidney injury biomarkers; risk factors

Indexed keywords

ALBUMIN; ANTIGEN; BETA 2 MICROGLOBULIN; CREATININE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE M1; IOHEXOL; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROGEN; OSTEOPONTIN; RENAL PAPILLARY ANTIGEN 1; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE MARKER; ESSENTIAL HYPERTENSION; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CONTRAST NEPHROPATHY; KIDNEY INJURY BIOMARKERS.; RISK FACTORS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CONTRAST MEDIA; DIABETES MELLITUS; HYPERTENSION; IOHEXOL; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; RATS; RATS, INBRED DAHL; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; ROC CURVE;

EID: 84878219095     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312464122     Document Type: Article

References (56)

1. Aigner F. Maier H. T. Schwelberger H. G. Wallnofer E. A. Amberger A. Obrist P. Berger T. Mak T. W. Maglione M. Margreiter R. Schneeberger S. Troppmair J. (2007). Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 7, 779–88.
2. Baumgarten D. A. Ellis J. H. (2008). Contrast-induced nephropathy: Contrast material not required? AJR Am J Roentgenol 191, 383–86.
3. Betton G. R. Ennulat D. Hoffman D. Gautier J. C. Harpur E. Pettit S. (2012). Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic acid. Toxicol Pathol (epub ahead of print; Feb 1, 2012).
4. Bu D. X. Hemdahl A. L. Gabrielsen A. Fuxe J. Zhu C. Eriksson P. Yan Z. Q. (2006). Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am. J Pathol 169, 2245–53.
5. Dieterle F. Perentes E. Cordier A. Roth D. R. Verdes P. Grenet O. Pantano S. Moulin P. Wahl D. Mahl A. End P. Staedtler F. Legay F. Carl K. Laurie D. Chibout S. D. Vonderscher J. Maurer G. (2010) Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 28, 463–69.
6. Duarte C. C. Zhang J. Ellis S. (1997). The spontaneouly hypertensive rat as a small animal model for radiocontrast renal failure. Renal Fail 19, 723–43.
7. Duarte C. C. Zhang J. Ellis S. (1998). Effects of radiocontrasts and endothelin on systolic blood pressure and renal damage in male SHR and WKY with phenolamine induced adrenergic blockage. Invest Radiol 33, 104–12.
8. Duarte C. C. Zhang J. Ellis S. (1999). Effects of radiocontrast, mannitol, and endothelin on blood pressure and renal damage in the aging male spontaneously hypertensive rat. Invest Radiol 34, 455–62.
9. Finn W. F. (2006). The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 21: i2–10.
10. Goldfarb S. (2005). Contrast-induced nephrotoxicity: Risk factors, pathophysiology, and prevention. www.appliedradiology.com. Online Supplement to Applied Radio, 5–6.
11. Goldfarb S. McCullough P. A. McDermott J. Gay S. B. (2009). Contrast-induced acute kidney injury: Specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 84, 170–79.
12. Harpur E. Ennulat D. Hoiffman D. Betton D. Gautier J. C. Riefke B. Bounous D. Schuster K. Beushausen S. Guffroy M. shaw M. Lock E. Pettit S., HESI Committee on Biomarkers of Nephrotoxicity. (2011). Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. Toxicol Sci 122, 235–52.
13. Ichimura T. Hung C. C. Yang S. A. Stevens J. L. Bonventre J. V. (2004). Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 286, F552–63.
14. Katzberg R. W. Lamba R. (2009). Contrast-induced nephropathy after intravenous administration: Fact or fiction? Radiol Clin North Am 47, 789–800.
15. Kuwabara T. Mori K. Mukoyama M. Kasahara M. Yokoi H. Saito Y. Yoshioka T. Ogawa Y. Imamaki H. Kusakabe T. Ebihara K. Omata M. Satoh N. Sugawara A. Barasch J. Nakao K. (2009). Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 75, 285–294.
16. Lebkowska U. Malyszko J. Lebkowska A. Koc-Zorawska E. Lebkowski W. Malyszko J. S. Kowalewski R. Gacko M. (2009). Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: A prospective study. Transplant Proc 41, 154–57.
17. Lock E. A. (2010). Sensitive and early markers of renal injury: Where are we and what is the way forward? Toxicol Sci 116, 1–4.
18. Maeda M. Yabuki A. Suzuki S. Matsumoto M. Taniguchi K. Nishinakagawa H. (2003). Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: Acute phase of diabetes. Vet Pathol 40, 187–95.
19. Makris K. Markou N. Evodia E. Dimopoulou E. Drakopoulos I. Ntetsika K. Rizos D. Baltopoulos G. Haliassos A. (2009). Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 47, 79–82.
20. Malyszko J. Malyszko J. S. Bachorzewska-Gajewska H. Poniatowski B. Dobrzycki S. Mysliwiec M. (2009). Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc 41, 158–61.
21. McCullough P. (2006). Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67, 335–43.
22. McCullough P. A. (2009). Commentary: Contrast-induced nephropathy and long-term adverse events: Cause and effect? Nephrol Dial Transplant 24, 3578–79.
23. Mehta R. L. Kellum J. A. Shah S. V. Molitoris B. A. Ronco C. Warnock D. G. Levin A. (2007). Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11, R31.
24. Morcos S. K. (1998). Contrast media-induced nephrotoxicity--questions and answers. Br J Radiol 71, 357–65.
25. Nagae A. Fujita M. Kawarazaki H. Matsui H. Ando K. Fujita T. (2009). Effect of high fat loading in Dahl salt-sensitive rats. Clin Exp Hypertens 31, 451–61.
26. Newman D. J. Mattock M. B. Dawnay A. B. Kerry S. McGuire A. Yaqoob M. Hitman G. A. Hawke C. (2005). Systematic review on urine albumin testing or early detection of diabetic complications. Health Technol Assess 9, 3–163.
27. Pannu N. Wiebe N. Tonelli M. (2006). Prophylaxis strategies for contrast-induced nephropathy. JAMA 295, 2765–69.
28. Perazella M. A. (2009). Radiocontrast-induced nephropathy: An update. Minerva Urol nefrol 61, 215–33.
29. Persy V. P. Verstrepen W. A. Ysebaert D. K. De Greef K. E. De Broe M. E. (1999). Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. Kidney Int 56, 601–11.
30. Prozialeck W. C. Vaidya V. S. Liu J. Waalkes M. P. Edwards J. R. Lamar P. C. Bernard A. M. Dumont X. Bonventre J. V. (2007). Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 72, 985–93.
31. Rached E. Hoffmann D. Blumbach K. Weber K. Dekant W. Mally A. (2008). Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro. Toxicol Sci 103, 371–81.
32. Rouse R. L. Zhang J. Stewart S. R. Rosenzweig B. A. Espandiari P. Sadrieh N. K. (2011). Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 79, 1186–97.
33. V.F., Seabra, M.C., Perianayagam, H., Tighiouart, O., Liangos, O.O.P., dos Santos, B.L., Jaber, Urinary α-GST and π-GST for prediction of dialysis requirement or in in-hospital death in established acute kidney injury, Biomarkers, (2011), 16, 709-717
34. Sieber M. Hoffmann D. Adler M. Vaidya V. S. Clement M. Bonventre J. V. Zidek N. Rached E. Amberg A. Callanan J. J. Dekant W. Mally A. (2009). Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 109, 336–49.
35. Simchon S. Manger W. M. Carlin R. D. Peeters L. L. Rodriguez J. Batista D. Brown T. Merchant N. B. Jan K. M. Chien S. (1989). Salt-induced hypertension in Dahl salt-sensitive rats. Hemodynamics and renal responses. Hypertension 13, 612–21.
36. Sirota J. C. Klawitter J. Edelstein C. L. (2011). Biomarkers of acute kidney injury. J Toxicol 2011, 328120. Epub October 29, 2011
37. Solomon R. (2008). Contrast-induced acute kidney injury: Is there a risk after intravenous contrast? Clin J Am Soc Nephrol 3, 1242–43.
38. Solomon R. (2009). Contrast-induced acute kidney injury (CIAKI). Radiol Clin North Am 47, 783–88.
39. Solomon R. Dumouchel W. (2006). Contrast media and nephropathy: Findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol 41, 651–60.
40. Solomon R. Segal A. (2008). Defining acute kidney injury: What is the most appropriate metric? Nat Clin Pract Nephrol 4, 208–15.
41. Solomon R. J. Mehran R. Natarajan M. K. Doucet S. Katholi R. E. Staniloae C. S. Sharma S. K. Labinaz M. Gelormini J. L. Barrett B. J. (2009). Contrast-induced nephropathy and long-term adverse events: Cause and effect? Clin J Am Soc Nephrol 4, 1162–69.
42. Thomsen H. Morcos S. (2003). Contrast media and the kidney: European Society of Urogential Radiology (ESUR) Guidelines. Br J Radiol 76, 513–18.
43. Tumlin J. Fulvio S. Adam A. Becker C. R. Davidson C. Lameire N. McCullough P. A. (2006). Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98, 14k–20k.
44. Vaidya V. S. Ferguson M. A. Bonventre J. V. (2008). Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48, 463–93.
45. von Eynatten M. Baumann M. Heemann U. Zdunek D. Hess G. Nawroth P. P. Bierhaus A. Humpert P. M. (2010). Urinary L-FABP and anaemia: Distinct roles of urinary markers in type 2 diabetes. Eur J Clin Invest 40, 95–102.
46. Waikar S. S. Bonventre J. V. (2009). Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20, 672–79.
47. Wang E. J. Snyder R. D. Fielden M. R. Smith R. J. Gu Y. Z. (2008). Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 246, 91–100.
48. Wang Y. Lam K. S. Kraegen E. W. Sweeney G. Zhang J. Tso A. W. Chow W. S. Wat N. M. Xu J. Y. Hoo R. L. Xu A. (2007). Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53, 34–41.
49. Xie M. J. Motoo Y. Su S. B. Sawabu N. (2001). Expression of clusterin in pancreatic acinar cell injuries in vivo and in vitro. Pancreas 22, 126–34.
50. Zafar M. Naqvi S. N. Ahmed M. Kaimkhani Z. A. (2009a). Altered liver morphology and enzymes in streptozotocin induced diabetic rats. Int J Morphol 27, 719–25.
51. Zafar M. Naqvi S. N. Ahmed M. Kaimkhani Z. A. (2009b). Altered kidney morphology and enzymes in streptozotocin induced diabetic rats. Int J Morphol 27, 783–90.
52. Zhang J. Brown R. P. Vaidya V. S. Zhou Y. Espandiari P. Sadrieh N. Stratmeyer M. Keenan J. Killy C. G. Bonventre J. V. Goering P. L. (2008). Immunolocalization of Kim-1, RPA-1, RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distribution of iNOs and nitrotyrosine. Toxicol Pathol 36, 367–409.
53. Zhang J. Duarte C. D. Ellis S. (1999). Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol Pathol 27, 427–35.
54. Zhang J. Hanig J. P. De Felice A. F. (2012). Biomarkers of endothelial cell activation: Candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals. Vascul Pharmacol 56, 14–25.
55. Zhang J. J. Yoshida H. Chao L. Chao J. (2000). Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Hum. Gene Ther 11, 1817–27.
56. Zhou Y. Vaidya V. S. Brown R. P. Zhang J. Rosenzweig B. A. Thompson K. L. Miller T. J. Bonventre J. V. Goering P. L. (2008). Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 101, 159–70.